<html>
<head>PUBMED IDs for D2HGD</head>
<body bgcolor='#C5F0F2'><h1>D2HGD</h1><a href='https://pubmed.ncbi.nlm.nih.gov/16601864/'>D-2-Hydroxyglutaric aciduria: unravelling the biochemical pathway and the genetic defect.</a> April 8  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16601852/'>Haemophilia A in a female caused by coincidence of a Swyer syndrome and a missense mutation in factor VIII gene.</a> April 8  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16601851/'>Haemophilia A, factor VIII intron 22 inversion screening using subcycling-PCR.</a> April 8  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/19169842/'>Peripheral neuropathy in a patient with D-2-hydroxyglutaric aciduria.</a> August 6  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19283509/'>Measurement of D: -2-hydroxyglutarate dehydrogenase activity in cell homogenates derived from D: -2-hydroxyglutaric aciduria patients.</a> July 17  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20020533/'>Evidence for genetic heterogeneity in D-2-hydroxyglutaric aciduria.</a> October 30  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/21625441/'>Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH mutations in glioblastoma.</a> December 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22683334/'>IDH1 and IDH2 have critical roles in 2-hydroxyglutarate production in D-2-hydroxyglutarate dehydrogenase depleted cells.</a> September 21  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23073310/'>The 2q37-deletion syndrome: an update of the clinical spectrum including overweight, brachydactyly and behavioural features in 14 new patients.</a> October 22  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23403238/'>Prenatal diagnosis of ring chromosome 2 with lissencephaly and 2p25.3 and 2q37.3 microdeletions detected using array comparative genomic hybridization.</a> May 22  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25811964/'>Derivatives containing both coumarin and benzimidazole potently induce caspase-dependent apoptosis of cancer cells through inhibition of PI3K-AKT-mTOR signaling.</a> November 17  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25825982/'>D-2-hydroxyglutarate is essential for maintaining oncogenic property of mutant IDH-containing cancer cells but dispensable for cell growth.</a> February 13  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26178471/'>D2HGDH regulates alpha-ketoglutarate levels and dioxygenase function by modulating IDH2.</a> April 14  2015<br></body></html>
